Therapeutic areas and clinical trial phases 1-4 performed in the United States:
American SciTech Intl. is the safest place in the United States to conduct Phase 1 clinical trials. We have well equipped well established hospitals and investigator physicians dedicated to safety of the study subjects and accuracy of the result during clinical Trials. We conduct all phases of clinical trials; Phase1-4 at the national and international levels.

Clinical trial with Monoclonal Antibody:
American SciTech International is one of the best centers committed to conduct clinical trials with Human Monoclonal Antibody designed for the treatment of various rare diseases, immune response systems, infectious disease, and malignancies. We work with pure human monoclonal antibodies’ and also monoclonal antibodies attached to radioisotope element.
Expertise in various therapeutic areas:

We have broad-based experience in conducting clinical trials in various therapeutic areas. Our outstanding record and experience in clinical trials in Cardiology, Endocrinology, Infectious Diseases, Immune Response Diseases, Neurology, oncology, and Psychiatry, respiratory and gastroenterology, has given us a unique place in the clinical trial field.

We also specializes in clinical research related to Pain Management, Rheumatology and other Auto-immune Diseases
Various indwelling devices:

We have also served many national and international biotech and pharmaceutical companies for indwelling devices.

Experience in Oncology Clinical Trial Management Oncology CRO services
We offer complete expertise in planning, designing and managing oncology clinical trial from Phase 1 through Phase 111.
American SciTech International has experience team to plan drug development strategy efficiently and carefully according to your needs and scientific requirements. Our experienced business analyst can assist on budgeting and managing financial aspects of clinical trial.
We specialized in therapeutic oncology clinical trials:
Our outstanding experience in oncology clinical trial management will help accomplish your goal. Contact us for details about the trials; Following is the list but not limited to the listing given below.

• Phase 111 Clinical Trial on advanced Stage of Multiple Myeloma with human monoclonal antibodies:

Industrial Sponsor: U.S Based biopharmaceutical industry. International multiple center///Total patients’ population worldwide planned until 2010 is 1200 patients.
CTMS: project management, clinical monitoring and maintaining case report forms,
SAE reporting, IND safety reporting, clinical data management, biostatistics analysis support and working within the budget. Current Status: Web Based Electronic data capture system of clinical trial: ongoing until December 2010

• Phase 2 Clinical Trial Generalized malignant Ascites & Pleural effusions

Industrial Sponsor: International Biopharmaceutical Company. Multiple-center international ///208 patients are participating in the study
Management: project Management, clinical monitoring and maintaining case report forms, SAE reporting, IND safety reporting, clinical data management, biostatistics analysis support and working within the budget. Current status: web based Electronic data Capture System of clinical Trial: Ongoing until December 2009

• Phases 2 clinical trial for ovarian malignancies

Industrial Sponsors: international biotech Company based in Europe//European Union & APEC//ASEAN chapter
Multiple international sites//132 Patients are participating in the study
CTMS: Project management, clinical monitoring and maintaining case report forms, SAE reporting, IND safety reporting, clinical data management, biostatistics analysis support and working within the budget. Current status: web based Clinical Trial is ongoing until December 2009

• Phase 1 Clinical trial : chronic lymphocytic leukemia

Industrial sponsor: Private U.S Pharmaceutical Company. Multi-center//26 patients are participating in the study.CTMS: project management, clinical monitoring and maintaining case report forms, SAE reporting, IND safety reporting, clinical data management, biostatistics analysis support and working within the budget. Current status: Clinical Trial is ongoing until mid-July 2008

• Phase 0 & 1 clinical Trial for common solid tumors with dose escalation

Industrial Sponsors: U.S public pharmaceutical company
Multiple sites///30 Patients are participating in the study
CTMS: Project management, clinical monitoring and maintaining case report forms, SAE reporting, IND safety reporting, clinical data management, biostatistics analysis support and working within the budget. Current status: web based clinical trial is ongoing until fall 2008

• Phase 0 & 1 Clinical Trial for Common solid tumors with dose Escalation

Industry sponsors: U.S. public pharmaceutical company
Multiple sites///30 Patients are participating in the study
CTMS: Project management, clinical data management, biostatistics analysis support and working within the budget. Current status: web based clinical trial is ongoing until fall 2008

• Phase 1 Non-Hodgkin’s lymphoma (first-in-human)

Industrial sponsors: Medical device and Biopharmaceutical Company
Multi-center study/// 57 Patients are participating in the study
Project management, clinical monitoring and maintaining case report forms, SAE reporting, IND safety reporting, clinical data management, biostatistics analysis support and working within the budget. Current status: Clinical Trial is ongoing until end of 2008

• Phase 1 Multiple myeloma advance stage Treatment with human monoclonal antibody with radio isotope attachment

Industrial Sponsor: European Union based public biotechnology company
Multiple centers/// 23 Patients are participating in the study. CTMS: Project management, clinical monitoring and maintaining case report forms, SAE reporting, IND safety reporting, clinical data management, biostatistics analysis support and working within the budget.
Current Status: Completed end of Dec 2005 and study started on Phase 2 Nov 2007